Hormones, growth factors, electrical stimulation, and cell–cell interactions regulate numerous cellular processes by altering the levels of second messengers, thus influencing biochemical reactions inside the cells. The Protein Kinase C family (PKCs) is a group of serine/threonine kinases that are dependent on calcium (Ca2+), diacylglycerol, and phospholipids. Signaling pathways that induce variations on the levels of PKC activators have been implicated in the regulation of diverse cellular functions and, in turn, PKCs are key regulators of a plethora of cellular processes, including proliferation, differentiation, and tumorigenesis. Importantly, PKCs contain regions, both in the N-terminal regulatory domain and in the C-terminal catalytic domain, that are susceptible to redox modifications. In several pathophysiological conditions when the balance between oxidants, antioxidants, and alkylants is compromised, cells undergo redox stress. PKCs are cell-signaling proteins that are particularly sensitive to redox stress because modification of their redox-sensitive regions interferes with their activity and, thus, with their biological effects. In this review, we summarize the involvement of PKCs in health and disease and the importance of redox signaling in the regulation of this family of kinases. Antioxid. Redox Signal. 13, 1051–1085.
AguiariP, LeoS, ZavanB, VindigniV, RimessiA, BianchiK, FranzinC, CortivoR, RossatoM, VettorR, AbatangeloG, PozzanT, PintonP, RizzutoR. High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc Natl Acad Sci USA, 105:1226–1231. 2008.
2.
AkmanSA, KenslerTW, DoroshowJH, DizdarogluM. Copper ion-mediated modification of bases in DNA in vitro by benzoyl peroxide. Carcinogenesis, 14:1971–1974. 1993.
3.
AlbanesD, HeinonenOP, HuttunenJK, TaylorPR, VirtamoJ, EdwardsBK, HaapakoskiJ, RautalahtiM, HartmanAM, PalmgrenJet al.Effects of alpha-tocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr, 62:1427S–1430S. 1995.
4.
AlcortaDA, XiongY, PhelpsD, HannonG, BeachD, BarrettJC. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA, 93:13742–13747. 1996.
5.
AlonsoM, MedinaJH, Pozzo–MillerL. ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. Learn Mem, 11:172–178. 2004.
AnisimovVN. Effects of exogenous melatonin—A review. Toxicol Pathol, 31:589–603. 2003.
8.
ArguinG, Regimbald–DumasY, FregeauMO, CaronAZ, GuillemetteG. Protein kinase C phosphorylates the inositol 1,4,5-trisphosphate receptor type 2 and decreases the mobilization of Ca2+ in pancreatoma AR4-2J cells. J Endocrinol, 192:659–668. 2007.
9.
AshkenaziA, DixitVM. Death receptors: Signaling and modulation. Science, 281:1305–1308. 1998.
10.
Azevedo–MartinsAK, LortzS, LenzenS, CuriR, EizirikDL, TiedgeM. Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappaB activation in insulin-producing cells. Diabetes, 52:93–101. 2003.
11.
BainesCP, SongCX, ZhengYT, WangGW, ZhangJ, WangOL, GuoY, BolliR, CardwellEM, PingP. Protein kinase Cepsilon interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ Res, 92:873–880. 2003.
12.
BansodeRR, HuangW, RoySK, MehtaM, MehtaKD. Protein kinase C deficiency increases fatty acid oxidation and reduces fat storage. J Biol Chem, 283:231–236. 2008.
13.
BarsacchiR, CoassinM, MaiorinoM, PelosiG, SimonelliC, UrsiniF. Increased ultra weak chemiluminescence emission from rat heart at postischemic reoxygenation: Protective role of vitamin E. Free Radic Biol Med, 6:573–579. 1989.
14.
BerraE, Diaz–MecoMT, DominguezI, MunicioMM, SanzL, LozanoJ, ChapkinRS, MoscatJ. Protein kinase C zeta isoform is critical for mitogenic signal transduction. Cell, 74:555–563. 1993.
15.
BertolottoC, MaulonL, FilippaN, BaierG, AubergerP. Protein kinase C theta and epsilon promote T-cell survival by a rsk-dependent phosphorylation and inactivation of BAD. J Biol Chem, 275:37246–37250. 2000.
16.
BezombesC, de ThonelA, ApostolouA, LouatT, JaffrezouJP, LaurentG, Quillet–MaryA. Overexpression of protein kinase Czeta confers protection against antileukemic drugs by inhibiting the redox-dependent sphingomyelinase activation. Mol Pharmacol, 62:1446–1455. 2002.
17.
BezombesC, PloI, Mansat–De MasV, Quillet–MaryA, Negre–SalvayreA, LaurentG, JaffrezouJP. Oxidative stress-induced activation of Lyn recruits sphingomyelinase and is requisite for its stimulation by Ara-C. FASEB J, 15:1583–1585. 2001.
18.
BiN, MamrackMD. PMA inhibits the growth of human fibroblasts after the induction of immediate-early genes. Exp Cell Res, 212:105–112. 1994.
19.
BiglanKM, SchwidS, EberlyS, BlindauerK, FahnS, GorenT, KieburtzK, OakesD, PlumbS, SiderowfA, SternM, ShoulsonI. Rasagiline improves quality of life in patients with early Parkinson's disease. Mov Disord, 21:616–623. 2006.
20.
BjelakovicG, NikolovaD, SimonettiRG, GluudC. Antioxidant supplements for prevention of gastrointestinal cancers: A systematic review and meta-analysis. Lancet, 364:1219–1228. 2004.
21.
BlackJD. Protein kinase C-mediated regulation of the cell cycle. Front Biosci, 5:D406–423. 2000.
22.
BoazM, SmetanaS, WeinsteinT, MatasZ, GafterU, IainaA, KnechtA, WeissgartenY, BrunnerD, FainaruM, GreenMS. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial. Lancet, 356:1213–1218. 2000.
23.
BoenglerK, DodoniG, Rodriguez–SinovasA, CabestreroA, Ruiz–MeanaM, GresP, KonietzkaI, Lopez–IglesiasC, Garcia–DoradoD, Di LisaF, HeuschG, SchulzR. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res, 67:234–244. 2005.
24.
BouloumieA, MarumoT, LafontanM, BusseR. Leptin induces oxidative stress in human endothelial cells. FASEB J, 13:1231–1238. 1999.
25.
BowlingN, HuangX, SanduskyGE, FoutsRL, MintzeK, EstermanM, AllenPD, MaddiR, McCallE, VlahosCJ. Protein kinase C-alpha and -epsilon modulate connexin-43 phosphorylation in human heart. J Mol Cell Cardiol, 33:789–798. 2001.
26.
BrasierAR, JamaluddinM, HanY, PattersonC, RungeMS. Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor. Mol Cell Biochem, 212:155–169. 2000.
27.
BrunnerF. Dependence of endothelin-1 secretion on Ca2+Biochem Pharmacol, 49:1785–1791. 1995.
28.
BudasGR, ChurchillEN, Mochly–RosenD. Cardioprotective mechanisms of PKC isozyme-selective activators and inhibitors in the treatment of ischemia-reperfusion injury. Pharmacol Res, 55:523–536. 2007.
29.
CaronAZ, ChalouxB, ArguinG, GuillemetteG. Protein kinase C decreases the apparent affinity of the inositol 1,4,5-trisphosphate receptor type 3 in RINm5F cells. Cell Calcium, 42:323–331. 2007.
30.
CarterCA, KaneCJ. Therapeutic potential of natural compounds that regulate the activity of protein kinase C. Curr Med Chem, 11:2883–2902. 2004.
31.
ChalfantCE, OhnoS, KonnoY, FisherAA, BisnauthLD, WatsonJE, CooperDR. A carboxy-terminal deletion mutant of protein kinase C beta II inhibits insulin-stimulated 2-deoxyglucose uptake in L6 rat skeletal muscle cells. Mol Endocrinol, 10:1273–1281. 1996.
32.
ChenCH, BudasGR, ChurchillEN, DisatnikMH, HurleyTD, Mochly–RosenD. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science, 321:1493–1495. 2008.
33.
ChenCT, HsuSH, WeiYH. Upregulation of mitochondrial function and antioxidant defense in the differentiation of stem cells. Biochim Biophys Acta, 1800:257–263. 2009.
34.
ChenCT, ShihYR, KuoTK, LeeOK, WeiYH. Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells. Stem Cells, 26:960–968. 2008.
35.
ChenHC, BandyopadhyayG, SajanMP, KanohY, StandaertM, FareseRVJr., FareseRV. Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-beta-D-riboside (AICAR)-stimulated glucose transport. J Biol Chem, 277:23554–23562. 2002.
36.
ChenJL, LinHH, KimKJ, LinA, FormanHJ, AnnDK. Novel roles for protein kinase Cdelta-dependent signaling pathways in acute hypoxic stress-induced autophagy. J Biol Chem, 283:34432–34444. 2008.
37.
ChenJL, LinHH, KimKJ, LinA, OuJH, AnnDK. PKC delta signaling: A dual role in regulating hypoxic stress-induced autophagy and apoptosis. Autophagy, 5:244–246. 2009.
38.
ChenL, HahnH, WuG, ChenCH, LironT, SchechtmanD, CavallaroG, BanciL, GuoY, BolliR, DornGW2nd, Mochly–RosenD. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci USA, 98:11114–11119. 2001.
39.
ChmuraSJ, NodzenskiE, WeichselbaumRR, QuintansJ. Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase. Cancer Res, 56:2711–2714. 1996.
40.
ChouWH, MessingRO. Protein kinase C isozymes in stroke. Trends Cardiovasc Med, 15:47–51. 2005.
ChurchillEN, MurrielCL, ChenCH, Mochly–RosenD, SzwedaLI. Reperfusion-induced translocation of deltaPKC to cardiac mitochondria prevents pyruvate dehydrogenase reactivation. Circ Res, 97:78–85. 2005.
43.
ChurchillEN, SzwedaLI. Translocation of deltaPKC to mitochondria during cardiac reperfusion enhances superoxide anion production and induces loss in mitochondrial function. Arch Biochem Biophys, 439:194–199. 2005.
Clapp–LillyKL, SmithMA, PerryG, HarrisPL, ZhuX, DuffyLK. Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease. Neuroreport, 12:1277–1280. 2001.
46.
CostaAD, JakobR, CostaCL, AndrukhivK, WestIC, GarlidKD. The mechanism by which the mitochondrial ATP-sensitive K+ channel opening and H2O2 inhibit the mitochondrial permeability transition. J Biol Chem, 281:20801–20808. 2006.
47.
CrossTG, Scheel–ToellnerD, HenriquezNV, DeaconE, SalmonM, LordJM. Serine/threonine protein kinases and apoptosis. Exp Cell Res, 256:34–41. 2000.
48.
CuervoAM. Autophagy: In sickness and in health. Trends Cell Biol, 14:70–77. 2004.
49.
da Cruz e SilvaOA, RebeloS, VieiraSI, GandyS, da Cruz e SilvaEF, GreengardP. Enhanced generation of Alzheimer's amyloid-beta following chronic exposure to phorbol ester correlates with differential effects on alpha and epsilon isozymes of protein kinase C. J Neurochem, 108:319–330. 2009.
50.
DaltonTP, ShertzerHG, PugaA. Regulation of gene expression by reactive oxygen. Annu Rev Pharmacol Toxicol, 39:67–101. 1999.
51.
Das EvcimenN, KingGL. The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res, 55:498–510. 2007.
52.
DavisPJ, DavisFB. Nongenomic actions of thyroid hormone on the heart. Thyroid, 12:459–466. 2002.
53.
DenningMF, DlugoszAA, ThreadgillDW, MagnusonT, YuspaSH. Activation of the epidermal growth factor receptor signal transduction pathway stimulates tyrosine phosphorylation of protein kinase C delta. J Biol Chem, 271:5325–5331. 1996.
54.
DetjenKM, BrembeckFH, WelzelM, KaiserA, HallerH, WiedenmannB, RosewiczS. Activation of protein kinase Calpha inhibits growth of pancreatic cancer cells via p21(cip)-mediated G(1) arrest. J Cell Sci, 113:3025–3035. 2000.
55.
DobleBW, PingP, KardamiE. The epsilon subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ Res, 86:293–301. 2000.
56.
DomenicottiC, PaolaD, VitaliA, NittiM, CottalassoD, MelloniE, PoliG, MarinariUM, PronzatoMA. Mechanisms of inactivation of hepatocyte protein kinase C isoforms following acute ethanol treatment. Free Radic Biol Med, 25:529–535. 1998.
57.
DoolanCM, CondliffeSB, HarveyBJ. Rapid nongenomic activation of cytosolic cyclic AMP-dependent protein kinase activity and [Ca(2+)](i) by 17beta-oestradiol in female rat distal colon. Br J Pharmacol, 129:1375–1386. 2000.
58.
DornGW2nd, SouroujonMC, LironT, ChenCH, GrayMO, ZhouHZ, CsukaiM, WuG, LorenzJN, Mochly–RosenD. Sustained in vivo cardiac protection by a rationally designed peptide that causes epsilon protein kinase C translocation. Proc Natl Acad Sci USA, 96:12798–12803. 1999.
59.
Dos SantosP, KowaltowskiAJ, LaclauMN, SeetharamanS, PaucekP, BoudinaS, ThamboJB, TariosseL, GarlidKD. Mechanisms by which opening the mitochondrial ATP-sensitive K(+) channel protects the ischemic heart. Am J Physiol Heart Circ Physiol, 283:H284–295. 2002.
DriesDR, GallegosLL, NewtonAC. A single residue in the C1 domain sensitizes novel protein kinase C isoforms to cellular diacylglycerol production. J Biol Chem, 282:826–830. 2007.
62.
EisenA, FismanEZ, RubenfireM, FreimarkD, McKechnieR, TenenbaumA, MotroM, AdlerY. Ischemic preconditioning: Nearly two decades of research. A comprehensive review. Atherosclerosis, 172:201–210. 2004.
63.
ErikssonJW. Metabolic stress in insulin's target cells leads to ROS accumulation. A hypothetical common pathway causing insulin resistance. FEBS Lett, 581:3734–3742. 2007.
64.
EslerWP, WolfeMS. A portrait of Alzheimer secretases—New features and familiar faces. Science, 293:1449–1454. 2001.
65.
EtcheberrigarayR, TanM, DewachterI, KuiperiC, Van der AuweraI, WeraS, QiaoL, BankB, NelsonTJ, KozikowskiAP, Van LeuvenF, AlkonDL. Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice. Proc Natl Acad Sci USA, 101:11141–11146. 2004.
66.
FareseRV, SajanMP, StandaertML. Atypical protein kinase C in insulin action and insulin resistance. Biochem Soc Trans, 33:350–353. 2005.
67.
FareseRV, SajanMP, YangH, LiP, MastoridesS, GowerWRJr., NimalS, ChoiCS, KimS, ShulmanGI, KahnCR, BraunU, LeitgesM. Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes. J Clin Invest, 117:2289–2301. 2007.
68.
FerrisCD, HuganirRL, BredtDS, CameronAM, SnyderSH. Inositol trisphosphate receptor: Phosphorylation by protein kinase C and calcium calmodulin-dependent protein kinases in reconstituted lipid vesicles. Proc Natl Acad Sci USA, 88:2232–2235. 1991.
69.
FilomenkoR, Poirson–BichatF, BillereyC, BelonJP, GarridoC, SolaryE, BettaiebA. Atypical protein kinase C zeta as a target for chemosensitization of tumor cells. Cancer Res, 62:1815–1821. 2002.
FinkelT, HolbrookNJ. Oxidants, oxidative stress and the biology of aging. Nature, 408:239–247. 2000.
72.
FlahertyJT, PittB, GruberJW, HeuserRR, RothbaumDA, BurwellLR, GeorgeBS, KereiakesDJ, DeitchmanD, GustafsonNet al.Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation, 89:1982–1991. 1994.
73.
FormisanoP, OrienteF, FioryF, CarusoM, MieleC, MaitanMA, AndreozziF, VigliottaG, CondorelliG, BeguinotF. Insulin-activated protein kinase Cbeta bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells. Mol Cell Biol, 20:6323–6333. 2000.
74.
FrojdoS, VidalH, PirolaL. Alterations of insulin signaling in type 2 diabetes: A review of the current evidence from humans. Biochim Biophys Acta, 1792:83–92. 2009.
75.
FryerRM, WangY, HsuAK, GrossGJ. Essential activation of PKC-delta in opioid-initiated cardioprotection. Am J Physiol Heart Circ Physiol, 280:H1346–1353. 2001.
76.
FuscoD, CollocaG, Lo MonacoMR, CesariM. Effects of antioxidant supplementation on the aging process. Clin Interv Aging, 2:377–387. 2007.
GavrielidesMV, FrijhoffAF, ContiCJ, KazanietzMG. Protein kinase C and prostate carcinogenesis: Targeting the cell cycle and apoptotic mechanisms. Curr Drug Targets, 5:431–443. 2004.
81.
Gilgun–SherkiY, MelamedE, OffenD. Oxidative stress induced-neurodegenerative diseases: The need for antioxidants that penetrate the blood brain barrier. Neuropharmacology, 40:959–975. 2001.
82.
GiorgioM, MigliaccioE, OrsiniF, PaolucciD, MoroniM, ContursiC, PellicciaG, LuziL, MinucciS, MarcaccioM, PintonP, RizzutoR, BernardiP, PaolucciF, PelicciPG. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell, 122:221–233. 2005.
83.
GopalakrishnaR, AndersonWB. Susceptibility of protein kinase C to oxidative inactivation: Loss of both phosphotransferase activity and phorbol diester binding. FEBS Lett, 225:233–237. 1987.
84.
GopalakrishnaR, AndersonWB. Ca2+- and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Natl Acad Sci USA, 86:6758–6762. 1989.
85.
GopalakrishnaR, ChenZH, GundimedaU. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J Biol Chem, 268:27180–27185. 1993.
86.
GopalakrishnaR, ChenZH, GundimedaU. Tobacco smoke tumor promoters, catechol and hydroquinone, induce oxidative regulation of protein kinase C and influence invasion and metastasis of lung carcinoma cells. Proc Natl Acad Sci USA, 91:12233–12237. 1994.
87.
GopalakrishnaR, ChenZH, GundimedaU. Modifications of cysteine-rich regions in protein kinase C induced by oxidant tumor promoters and enzyme-specific inhibitors. Methods Enzymol, 252:132–146. 1995.
88.
GopalakrishnaR, GundimedaU. Antioxidant regulation of protein kinase C in cancer prevention. J Nutr, 132:3819S–3823S. 2002.
89.
GopalakrishnaR, GundimedaU, SchiffmanJE, McNeillTH. A direct redox regulation of protein kinase C isoenzymes mediates oxidant-induced neuritogenesis in PC12 cells. J Biol Chem, 283:14430–14444. 2008.
90.
GopalakrishnaR, JakenS. Protein kinase C signaling and oxidative stress. Free Radic Biol Med, 28:1349–1361. 2000.
91.
GschwendtM, KittsteinW, MarksF. Protein kinase C activation by phorbol esters: Do cysteine-rich regions and pseudosubstrate motifs play a role?Trends Biochem Sci, 16:167–169. 1991.
92.
GubinaE, RinaudoMS, SzallasiZ, BlumbergPM, MufsonRA. Overexpression of protein kinase C isoform epsilon but not delta in human interleukin-3-dependent cells suppresses apoptosis and induces bcl-2 expression. Blood, 91:823–829. 1998.
93.
GundimedaU, HaraSK, AndersonWB, GopalakrishnaR. Retinoids inhibit the oxidative modification of protein kinase C induced by oxidant tumor promoters. Arch Biochem Biophys, 300:526–530. 1993.
94.
GuoD, NguyenT, OgbiM, TawfikH, MaG, YuQ, CaldwellRW, JohnsonJA. Protein kinase C-epsilon coimmunoprecipitates with cytochrome oxidase subunit IV and is associated with improved cytochrome-c oxidase activity and cardioprotection. Am J Physiol Heart Circ Physiol, 293:H2219–2230. 2007.
95.
GutteridgeJM, HalliwellB. Free radicals and antioxidants in the year 2000. A historical look to the future. Ann NY Acad Sci, 899:136–147. 2000.
96.
HaassC, De StrooperB. The presenilins in Alzheimer's disease—Proteolysis holds the key. Science, 286:916–919. 1999.
97.
HalestrapAP. Calcium, mitochondria and reperfusion injury: A pore way to die. Biochem Soc Trans, 34:232–237. 2006.
98.
HalestrapAP, ClarkeSJ, JavadovSA. Mitochondrial permeability transition pore opening during myocardial reperfusion—A target for cardioprotection. Cardiovasc Res, 61:372–385. 2004.
99.
HaraE, SmithR, ParryD, TaharaH, StoneS, PetersG. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol, 16:859–867. 1996.
100.
HaramakiN, PackerL, AssadnazariH, ZimmerG. Cardiac recovery during post-ischemic reperfusion is improved by combination of vitamin E with dihydrolipoic acid. Biochem Biophys Res Commun, 196:1101–1107. 1993.
101.
HarmanD. Aging: A theory based on free radical and radiation chemistry. J Gerontol, 11:298–300. 1956.
102.
HeL, SabetA, DjedjosS, MillerR, SunX, HussainMA, RadovickS, WondisfordFE. Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein. Cell, 137:635–646. 2009.
103.
HeichmanKA, RobertsJM. Rules to replicate by. Cell, 79:557–562. 1994.
104.
HerrlichP, BohmerFD. Redox regulation of signal transduction in mammalian cells. Biochem Pharmacol, 59:35–41. 2000.
105.
HiraiT, ChidaK. Protein kinase Czeta (PKCzeta): Activation mechanisms and cellular functions. J Biochem, 133:1–7. 2003.
106.
HolmuhamedovEL, WangL, TerzicA. ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria. J Physiol, 519:347–360. 1999.
107.
HondaK, CasadesusG, PetersenRB, PerryG, SmithMA. Oxidative stress and redox-active iron in Alzheimer's disease. Ann NY Acad Sci, 1012:179–182. 2004.
108.
Hoyer–HansenM, BastholmL, SzyniarowskiP, CampanellaM, SzabadkaiG, FarkasT, BianchiK, FehrenbacherN, EllingF, RizzutoR, MathiasenIS, JaattelaM. Control of macroautophagy by calcium, calmodulin-dependent kinase kinase-beta, and Bcl-2. Mol Cell, 25:193–205. 2007.
109.
HugH, SarreTF. Protein kinase C isoenzymes: Divergence in signal transduction?Biochem J, 291:329–343. 1993.
110.
HumphriesMJ, LimesandKH, SchneiderJC, NakayamaKI, AndersonSM, ReylandME. Suppression of apoptosis in the protein kinase Cdelta null mouse in vivo. J Biol Chem, 281:9728–9737. 2006.
111.
HundalRS, KrssakM, DufourS, LaurentD, LebonV, ChandramouliV, InzucchiSE, SchumannWC, PetersenKF, LandauBR, ShulmanGI. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes, 49:2063–2069. 2000.
112.
InagakiK, ChenL, IkenoF, LeeFH, ImahashiK, BouleyDM, RezaeeM, YockPG, MurphyE, Mochly–RosenD. Inhibition of delta-protein kinase C protects against reperfusion injury of the ischemic heart in vivo. Circulation, 108:2304–2307. 2003.
113.
InoueI, NagaseH, KishiK, HigutiT. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature, 352:244–247. 1991.
114.
IshiiH, JirousekMR, KoyaD, TakagiC, XiaP, ClermontA, BursellSE, KernTS, BallasLM, HeathWF, StrammLE, FeenerEP, KingGL. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science, 272:728–731. 1996.
115.
IsoharaT, HoriuchiA, WatanabeT, AndoK, CzernikAJ, UnoI, GreengardP, NairnAC, SuzukiT. Phosphorylation of the cytoplasmic domain of Alzheimer's beta-amyloid precursor protein at Ser655 by a novel protein kinase. Biochem Biophys Res Commun, 258:300–305. 1999.
116.
ItaniSI, ZhouQ, PoriesWJ, MacDonaldKG, DohmGL. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes, 49:1353–1358. 2000.
117.
JaneroDR, BurghardtB. Oxidative injury to myocardial membrane: Direct modulation by endogenous alpha-tocopherol. J Mol Cell Cardiol, 21:1111–1124. 1989.
118.
JarvisWD, FornariFAJr., BrowningJL, GewirtzDA, KolesnickRN, GrantS. Attenuation of ceramide-induced apoptosis by diglyceride in human myeloid leukemia cells. J Biol Chem, 269:31685–31692. 1994.
119.
JinZQ, ZhouHZ, ZhuP, HonboN, Mochly–RosenD, MessingRO, GoetzlEJ, KarlinerJS, GrayMO. Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts. Am J Physiol Heart Circ Physiol, 282:H1970–1977. 2002.
KaibuchiK, TakaiY, NishizukaY. Protein kinase C and calcium ion in mitogenic response of macrophage-depleted human peripheral lymphocytes. J Biol Chem, 260:1366–1369. 1985.
124.
KanazawaT, TaneikeI, AkaishiR, YoshizawaF, FuruyaN, FujimuraS, KadowakiM. Amino acids and insulin control autophagic proteolysis through different signaling pathways in relation to mTOR in isolated rat hepatocytes. J Biol Chem, 279:8452–8459. 2004.
125.
KanetoH, MatsuokaTA, NakataniY, KawamoriD, MatsuhisaM, YamasakiY. Oxidative stress and the JNK pathway in diabetes. Curr Diabetes Rev, 1:65–72. 2005.
126.
KaulS, AnantharamV, YangY, ChoiCJ, KanthasamyA, KanthasamyAG. Tyrosine phosphorylation regulates the proteolytic activation of protein kinase Cdelta in dopaminergic neuronal cells. J Biol Chem, 280:28721–28730. 2005.
127.
KaulS, KanthasamyA, KitazawaM, AnantharamV, KanthasamyAG. Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration. Eur J Neurosci, 18:1387–1401. 2003.
128.
KempBE, PearsonRB. Intrasteric regulation of protein kinases and phosphatases. Biochim Biophys Acta, 1094:67–76. 1991.
129.
KevinLG, CamaraAK, RiessML, NovalijaE, StoweDF. Ischemic preconditioning alters real-time measure of O2 radicals in intact hearts with ischemia and reperfusion. Am J Physiol Heart Circ Physiol, 284:H566–574. 2003.
130.
KhaliulinI, ClarkeSJ, LinH, ParkerJ, SuleimanMS, HalestrapAP. Temperature preconditioning of isolated rat hearts—A potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore. J Physiol, 581:1147–1161. 2007.
131.
KimHS, KregeJH, KluckmanKD, HagamanJR, HodginJB, BestCF, JennetteJC, CoffmanTM, MaedaN, SmithiesO. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA, 92:2735–2739. 1995.
132.
KingGL. The role of inflammatory cytokines in diabetes and its complications. J Periodontol, 79:1527–1534. 2008.
133.
KleinHH, PichS, Lindert–HeimbergS, NebendahlK, NiedmannP. Failure of chronic, high-dose, oral vitamin E treatment to protect the ischemic, reperfused porcine heart. J Mol Cell Cardiol, 25:103–112. 1993.
134.
KlonerRA, RezkallaSH. Preconditioning, postconditioning and their application to clinical cardiology. Cardiovasc Res, 70:297–307. 2006.
135.
KonishiH, TanakaM, TakemuraY, MatsuzakiH, OnoY, KikkawaU, NishizukaY. Activation of protein kinase C by tyrosine phosphorylation in response to H2O2. Proc Natl Acad Sci USA, 94:11233–11237. 1997.
136.
KonishiH, YamauchiE, TaniguchiH, YamamotoT, MatsuzakiH, TakemuraY, OhmaeK, KikkawaU, NishizukaY. Phosphorylation sites of protein kinase C delta in H2O2-treated cells and its activation by tyrosine kinase in vitro. Proc Natl Acad Sci USA, 98:6587–6592. 2001.
137.
KoyaD, KingGL. Protein kinase C activation and the development of diabetic complications. Diabetes, 47:859–866. 1998.
138.
KozikowskiAP, ChenY, SubhasishT, LewinNE, BlumbergPM, ZhongZ, D'AnnibaleMA, WangWL, ShenY, LangleyB. Searching for disease modifiers–PKC activation and HDAC inhibition. A dual drug approach to Alzheimer's disease that decreases Abeta production while blocking oxidative stress. Chem Med Chem, 4:1095–1105. 2009.
139.
KrenzM, OldenburgO, WimpeeH, CohenMV, GarlidKD, CritzSD, DowneyJM, BenoitJN. Opening of ATP-sensitive potassium channels causes generation of free radicals in vascular smooth muscle cells. Basic Res Cardiol, 97:365–373. 2002.
140.
KrishnamurthyJ, TorriceC, RamseyMR, KovalevGI, Al–RegaieyK, SuL, SharplessNE. Ink4a/Arf expression is a biomarker of aging. J Clin Invest, 114:1299–1307. 2004.
141.
KuHH, BrunkUT, SohalRS. Relationship between mitochondrial superoxide and hydrogen peroxide production and longevity of mammalian species. Free Radic Biol Med, 15:621–627. 1993.
142.
LeeS, LynnEG, KimJA, QuonMJ. Protein kinase C-zeta phosphorylates insulin receptor substrate-1, -3, and -4 but not -2: Isoform specific determinants of specificity in insulin signaling. Endocrinology, 149:2451–2458. 2008.
LevadeT, JaffrezouJP. Signaling sphingomyelinases: Which, where, how and why?Biochim Biophys Acta, 1438:1–17. 1999.
145.
LiX, RongY, ZhangM, WangXL, LeMaireSA, CoselliJS, ZhangY, ShenYH. Up-regulation of thioredoxin interacting protein (Txnip) by p38 MAPK and FOXO1 contributes to the impaired thioredoxin activity and increased ROS in glucose-treated endothelial cells. Biochem Biophys Res Commun, 381:660–665. 2009.
146.
LibermanZ, PlotkinB, TennenbaumT, Eldar–FinkelmanH. Coordinated phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 and protein kinase C betaII in the diabetic fat tissue. Am J Physiol Endocrinol Metab, 294:E1169–1177. 2008.
147.
LinMT, BealMF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature, 443:787–795. 2006.
148.
LindsayDG, AstleySB. European research on the functional effects of dietary antioxidants—EUROFEDA. Mol Aspects Med, 23:1–38. 2002.
149.
LironT, SerayaCB, Ish–ShalomM, SouroujonMC, NeumannD. Overexpression of amyloid precursor protein reduces epsilon protein kinase C levels. Neuroscience, 146:152–159. 2007.
150.
LiuJ, ChenJ, DaiQ, LeeRM. Phospholipid scramblase 3 is the mitochondrial target of protein kinase C delta-induced apoptosis. Cancer Res, 63:1153–1156. 2003.
151.
LiuYF, PazK, HerschkovitzA, AltA, TennenbaumT, SampsonSR, OhbaM, KurokiT, LeRoithD, ZickY. Insulin stimulates PKCzeta -mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins. J Biol Chem, 276:14459–14465. 2001.
152.
LivnehE, ShimonT, BechorE, DokiY, SchierenI, WeinsteinIB. Linking protein kinase C to the cell cycle: Ectopic expression of PKC eta in NIH3T3 cells alters the expression of cyclins and Cdk inhibitors and induces adipogenesis. Oncogene, 12:1545–1555. 1996.
LuT, PanY, KaoSY, LiC, KohaneI, ChanJ, YanknerBA. Gene regulation and DNA damage in the aging human brain. Nature, 429:883–891. 2004.
155.
LynchK, FernandezG, PappalardoA, PelusoJJ. Basic fibroblast growth factor inhibits apoptosis of spontaneously immortalized granulosa cells by regulating intracellular free calcium levels through a protein kinase Cdelta-dependent pathway. Endocrinology, 141:4209–4217. 2000.
156.
MaherP. How protein kinase C activation protects nerve cells from oxidative stress-induced cell death. J Neurosci, 21:2929–2938. 2001.
157.
MaingretteF, RenierG. Leptin increases lipoprotein lipase secretion by macrophages: Involvement of oxidative stress and protein kinase C. Diabetes, 52:2121–2128. 2003.
158.
MansatV, LaurentG, LevadeT, BettaiebA, JaffrezouJP. The protein kinase C activators phorbol esters and phosphatidylserine inhibit neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin. Cancer Res, 57:5300–534. 1997.
159.
Mansat–de MasV, BezombesC, Quillet–MaryA, BettaiebA, D'OrgeixA D, LaurentG, JaffrezouJP. Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicin. Mol Pharmacol, 56:867–874. 1999.
160.
Mansat–De MasV, de ThonelA, GaulinV, DemurC, LaurentG, Quillet–MaryA. Protein kinase C-zeta overexpression induces erythroid phenotype in the monocytic leukaemia cell line U937. Br J Haematol, 118:646–653. 2002.
161.
MaruyamaW, AkaoY, YoudimMB, DavisBA, NaoiM. Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug, rasagiline, prevent nuclear accumulation of glyceraldehyde-3-phosphate dehydrogenase induced by an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol. J Neurochem, 78:727–735. 2001.
162.
McGowanK, DeVenteJ, CareyJO, WaysDK, PekalaPH. Protein kinase C isoform expression during the differentiation of 3T3-L1 preadipocytes: Loss of protein kinase C-alpha isoform correlates with loss of phorbol 12-myristate 13-acetate activation of nuclear factor kappaB and acquisition of the adipocyte phenotype. J Cell Physiol, 167:113–120. 1996.
163.
MeijerAJ, CodognoP. Regulation and role of autophagy in mammalian cells. Int J Biochem Cell Biol, 36:2445–2462. 2004.
164.
MellorH, ParkerPJ. The extended protein kinase C superfamily. Biochem J, 332:281–292. 1998.
165.
MezosiE, SzaboJ, NagyEV, BorbelyA, VargaE, ParaghG, VargaZ. Nongenomic effect of thyroid hormone on free-radical production in human polymorphonuclear leukocytes. J Endocrinol, 185:121–129. 2005.
166.
MigliaccioE, GiorgioM, MeleS, PelicciG, ReboldiP, PandolfiPP, LanfranconeL, PelicciPG. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature, 402:309–313. 1999.
167.
MischakH, GoodnightJA, KolchW, Martiny–BaronG, SchaechtleC, KazanietzMG, BlumbergPM, PierceJH, MushinskiJF. Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J Biol Chem, 268:6090–6096. 1993.
168.
MiyamotoA, NakayamaK, ImakiH, HiroseS, JiangY, AbeM, TsukiyamaT, NagahamaH, OhnoS, HatakeyamaS, NakayamaKI. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cdelta. Nature, 416:865–869. 2002.
169.
Mochly–RosenD, KhanerH, LopezJ, SmithBL. Intracellular receptors for activated protein kinase C. Identification of a binding site for the enzyme. J Biol Chem, 266:14866–14868. 1991.
170.
MonteroM, BarreroMJ, AlvarezJ. [Ca2+] microdomains control agonist-induced Ca2+ release in intact HeLa cells. FASEB J., 11:881–885. 1997.
171.
MonteroM, LobatonCD, Gutierrez–FernandezS, MorenoA, AlvarezJ. Modulation of histamine-induced Ca2+ release by protein kinase C: Effects on cytosolic and mitochondrial [Ca2+] peaks. J Biol Chem, 278:49972–49979. 2003.
172.
MorelY, BaroukiR. Repression of gene expression by oxidative stress. Biochem J, 342:481–496. 1999.
173.
MoriI, IshizukaT, MoritaH, MatsumotoM, UnoY, KajitaK, IkedaT, FujiokaK, MatsubaraK. Comparison of biochemical data, blood pressure and physical activity between longevity and non-longevity districts in Japan. Circ J, 72:1680–1684. 2008.
174.
MurphyE, SteenbergenC. Preconditioning: The mitochondrial connection. Annu Rev Physiol, 69:51–67. 2007.
175.
MurrielCL, ChurchillE, InagakiK, SzwedaLI, Mochly–RosenD. Protein kinase Cdelta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: A mechanism involving BAD and the mitochondria. J Biol Chem, 279:47985–47991. 2004.
176.
MurryCE, JenningsRB, ReimerKA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation, 74:1124–1136. 1986.
177.
MuruganandanS, RomanAA, SinalCJ. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: Cross talk with the osteoblastogenic program. Cell Mol Life Sci, 66:236–253. 2009.
178.
NagataS. Apoptosis by death factor. Cell, 88:355–365. 1997.
179.
NakagawaM, OlivaJL, KothapalliD, FournierA, AssoianRK, KazanietzMG. Phorbol ester-induced G1 phase arrest selectively mediated by protein kinase Cdelta-dependent induction of p21. J Biol Chem, 280:33926–33934. 2005.
180.
NamJS, ChoMH, LeeGT, ParkJS, AhnCW, ChaBS, LimSK, KimKR, HaHJ, LeeHC. The activation of NF-kappaB and AP-1 in peripheral blood mononuclear cells isolated from patients with diabetic nephropathy. Diabetes Res Clin Pract, 81:25–32. 2008.
181.
NelsonTJ, SunMK, HongpaisanJ, AlkonDL. Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair. Eur J Pharmacol, 585:76–87. 2008.
182.
NishikawaT, ArakiE. Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications. Antioxid Redox Signal, 9:343–353. 2007.
183.
NishikawaT, EdelsteinD, DuXL, YamagishiS, MatsumuraT, KanedaY, YorekMA, BeebeD, OatesPJ, HammesHP, GiardinoI, BrownleeM. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404:787–790. 2000.
184.
NishizukaY. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science, 258:607–614. 1992.
185.
O'BrianCA, LiskampRM, SolomonDH, WeinsteinIB. Inhibition of protein kinase C by tamoxifen. Cancer Res, 45:2462–2465. 1985.
186.
O'RourkeB. Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ Res, 94:420–432. 2004.
187.
OanceaE, MeyerT. Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals. Cell, 95:307–318. 1998.
188.
OgbiM, ChewCS, PohlJ, StuchlikO, OgbiS, JohnsonJA. Cytochrome c oxidase subunit IV as a marker of protein kinase Cepsilon function in neonatal cardiac myocytes: Implications for cytochrome c oxidase activity. Biochem J, 382:923–932. 2004.
189.
OhsumiY. Molecular dissection of autophagy: Two ubiquitin-like systems. Nat Rev Mol Cell Biol, 2:211–216. 2001.
190.
OnoY, FujiiT, OgitaK, KikkawaU, IgarashiK, NishizukaY. The structure, expression, and properties of additional members of the protein kinase C family. J Biol Chem, 263:6927–6932. 1988.
191.
OrsiniF, MigliaccioE, MoroniM, ContursiC, RakerVA, PicciniD, Martin–PaduraI, PellicciaG, TrineiM, BonoM, PuriC, TacchettiC, FerriniM, MannucciR, NicolettiI, LanfranconeL, GiorgioM, PelicciPG. The life span determinant p66Shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates trans-membrane potential. J Biol Chem, 279:25689–25695. 2004.
192.
OsseniRA, RatP, BogdanA, WarnetJM, TouitouY. Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2. Life Sci, 68:387–399. 2000.
193.
OsterH, LeitgesM. Protein kinase C alpha but not PKCzeta suppresses intestinal tumor formation in ApcMin/+ mice. Cancer Res, 66:6955–6963. 2006.
194.
OstlundREJr., YangJW, KleinS, GingerichR. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab, 81:3909–3913. 1996.
PandeyP, NakazawaA, ItoY, DattaR, KharbandaS, KufeD. Requirement for caspase activation in monocytic differentiation of myeloid leukemia cells. Oncogene, 19:3941–3947. 2000.
197.
PaolaD, DomenicottiC, NittiM, VitaliA, BorghiR, CottalassoD, ZaccheoD, OdettiP, StrocchiP, MarinariUM, TabatonM, PronzatoMA. Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells. Biochem Biophys Res Commun, 268:642–646. 2000.
198.
PartridgeNC, BlochSR, PearmanAT. Signal transduction pathways mediating parathyroid hormone regulation of osteoblastic gene expression. J Cell Biochem, 55:321–327. 1994.
199.
PascaleA, FortinoI, GovoniS, TrabucchiM, WetselWC, BattainiF. Functional impairment in protein kinase C by RACK1 (receptor for activated C kinase 1) deficiency in aged rat brain cortex. J Neurochem, 67:2471–2477. 1996.
PearsonP, LewisSA, BrittonJ, YoungIS, FogartyA. The pro-oxidant activity of high-dose vitamin E supplements in vivo. BioDrugs, 20:271–273. 2006.
202.
PingP, ZhangJ, PierceWMJr., BolliR. Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection. Circ Res, 88:59–62. 2001.
203.
PingP, ZhangJ, QiuY, TangXL, ManchikalapudiS, CaoX, BolliR. Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res, 81:404–414. 1997.
204.
PintonP, GiorgiC, SivieroR, ZecchiniE, RizzutoR. Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene, 27:6407–6418. 2008.
205.
PintonP, LeoS, WieckowskiMR, Di BenedettoG, RizzutoR. Long-term modulation of mitochondrial Ca2+ signals by protein kinase C isozymes. J Cell Biol, 165:223–232. 2004.
206.
PintonP, RimessiA, MarchiS, OrsiniF, MigliaccioE, GiorgioM, ContursiC, MinucciS, MantovaniF, WieckowskiMR, Del SalG, PelicciPG, RizzutoR. Protein kinase C beta and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science, 315:659–663. 2007.
207.
PintonP, RimessiA, RomagnoliA, PrandiniA, RizzutoR. Biosensors for the detection of calcium and pH. Methods Cell Biol, 80:297–325. 2007.
208.
PintonP, RizzutoR. p66Shc, oxidative stress and aging: Importing a lifespan determinant into mitochondria. Cell Cycle, 7:304–308. 2008.
209.
PintonP, TsuboiT, AinscowEK, PozzanT, RizzutoR, RutterGA. Dynamics of glucose-induced membrane recruitment of protein kinase C beta II in living pancreatic islet beta-cells. J Biol Chem, 277:37702–37710. 2002.
PowellCT, BrittisNJ, StecD, HugH, HestonWD, FairWR. Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells. Cell Growth Differ, 7:419–428. 1996.
212.
PrevostelC, MartinA, AlvaroV, JaffiolC, JoubertD. Protein kinase C alpha and tumorigenesis of the endocrine gland. Horm Res, 47:140–144. 1997.
213.
PrzyklenkK. Pharmacologic treatment of the stunned myocardium: The concepts and the challenges. Coron Artery Dis, 12:363–369. 2001.
214.
RaabMS, BreitkreutzI, TononG, ZhangJ, HaydenPJ, NguyenT, FruehaufJH, LinBK, ChauhanD, HideshimaT, MunshiNC, AndersonKC, PodarK. Targeting PKC: A novel role for beta-catenin in ER stress and apoptotic signaling. Blood, 113:1513–1521. 2009.
215.
RacchiM, GovoniS, SolerteSB, GalliCL, CorsiniE. Dehydroepiandrosterone and the relationship with aging and memory: A possible link with protein kinase C functional machinery. Brain Res Brain Res Rev, 37:287–293. 2001.
216.
RacchiM, MazzucchelliM, PascaleA, SironiM, GovoniS. Role of protein kinase Calpha in the regulated secretion of the amyloid precursor protein. Mol Psychiat, 8:209–216. 2003.
217.
RahaS, MyintAT, JohnstoneL, RobinsonBH. Control of oxygen free radical formation from mitochondrial complex I: Roles for protein kinase A and pyruvate dehydrogenase kinase. Free Radic Biol Med, 32:421–430. 2002.
218.
Rask–MadsenC, KingGL. Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance. Arterioscler Thromb Vasc Biol, 25:487–496. 2005.
219.
RasolaA, BernardiP. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis, 12:815–833. 2007.
220.
RavichandranLV, EspositoDL, ChenJ, QuonMJ. Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. J Biol Chem, 276:3543–3549. 2001.
221.
ReavenGM. Insulin resistance: A chicken that has come to roost. Ann NY Acad Sci, 892:45–57. 1999.
222.
ReddyPH, McWeeneyS, ParkBS, ManczakM, GutalaRV, PartoviD, JungY, YauV, SearlesR, MoriM, QuinnJ. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: Up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum Mol Genet, 13:1225–1240. 2004.
223.
ReiterRJ. Oxidative damage in the central nervous system: Protection by melatonin. Prog Neurobiol, 56:359–384. 1998.
224.
RenierG, DesfaitsAC, LambertA, MikhailR. Role of oxidant injury on macrophage lipoprotein lipase (LPL) production and sensitivity to LPL. J Lipid Res, 37:799–809. 1996.
225.
ReylandME. Protein kinase Cdelta and apoptosis. Biochem Soc Trans, 35:1001–1004. 2007.
226.
ReylandME. Protein kinase C isoforms: Multi-functional regulators of cell life and death. Front Biosci, 14:2386–2399. 2009.
227.
RimessiA, RizzutoR, PintonP. Differential recruitment of PKC isoforms in HeLa cells during redox stress. Cell Stress Chaperones, 12:291–298. 2007.
228.
RizzutoR, MarchiS, BonoraM, AguiariP, BononiA, De StefaniD, GiorgiC, LeoS, RimessiA, SivieroR, ZecchiniE, PintonP. Ca(2+) transfer from the ER to mitochondria: When, how and why. Biochim Biophys Acta, 1787:1342–1351. 2009.
229.
RosenP, NawrothPP, KingG, MollerW, TritschlerHJ, PackerL. The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev, 17:189–212. 2001.
230.
RossnerS, MendlaK, SchliebsR, BiglV. Protein kinase Calpha and beta1 isoforms are regulators of alpha-secretory proteolytic processing of amyloid precursor protein in vivo. Eur J Neurosci, 13:1644–1648. 2001.
231.
RozengurtE. Early signals in the mitogenic response. Science, 234:161–166. 1986.
232.
RussellJH. Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol, 7:382–388. 1995.
233.
RuvoloPP, DengX, CarrBK, MayWS. A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis. J Biol Chem, 273:25436–25442. 1998.
234.
SakakiK, KaufmanRJ. Regulation of ER stress-induced macroautophagy by protein kinase C. Autophagy, 4:841–843. 2008.
235.
SakakiK, WuJ, KaufmanRJ. Protein kinase Ctheta is required for autophagy in response to stress in the endoplasmic reticulum. J Biol Chem, 283:15370–15380. 2008.
Santos–AlvarezJ, GobernaR, Sanchez–MargaletV. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol, 194:6–11. 1999.
238.
SatoT, O'RourkeB, MarbanE. Modulation of mitochondrial ATP-dependent K+ channels by protein kinase C. Circ Res, 83:110–114. 1998.
239.
SaurinAT, PenningtonDJ, RaatNJ, LatchmanDS, OwenMJ, MarberMS. Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts. Cardiovasc Res, 55:672–680. 2002.
240.
SchapiraAH, CooperJM, DexterD, JennerP, ClarkJB, MarsdenCD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet, 1:1269. 1989.
241.
SchechtmanD, Mochly–RosenD. Adaptor proteins in protein kinase C-mediated signal transduction. Oncogene, 20:6339–6347. 2001.
242.
SchwartzGK, JiangJ, KelsenD, AlbinoAP. Protein kinase C: A novel target for inhibiting gastric cancer cell invasion. J Natl Cancer Inst, 85:402–407. 1993.
243.
SlaterSJ, KellyMB, TaddeoFJ, LarkinJD, YeagerMD, McLaneJA, HoC, StubbsCD. Direct activation of protein kinase C by 1 alpha,25-dihydroxyvitamin D3. J Biol Chem, 270:6639–6643. 1995.
244.
SlezakJ, TribulovaN, PristacovaJ, UhrikB, ThomasT, KhaperN, KaulN, nd SingalPK. Hydrogen peroxide changes in ischemic and reperfused heart. Cytochemistry and biochemical and X-ray microanalysis. Am J Pathol, 147:772–781. 1995.
245.
SohalRS, MockettRJ, OrrWC. Mechanisms of aging: An appraisal of the oxidative stress hypothesis. Free Radic Biol Med, 33:575–586. 2002.
246.
SouroujonMC, Mochly–RosenD. Peptide modulators of protein–protein interactions in intracellular signaling. Nat Biotechnol, 16:919–924. 1998.
247.
StabelS, ParkerPJ. Protein kinase C. Pharmacol Ther, 51:71–95. 1991.
248.
SunB, MurrayNR, FieldsAP. A role for nuclear phosphatidylinositol-specific phospholipase C in the G2/M phase transition. J Biol Chem, 272:26313–26317. 1997.
249.
SunMK, AlkonDL. Protein kinase C pharmacology: Perspectives on therapeutic potentials as antidementic and cognitive agents. Recent Pat CNS Drug Discov, 1:147–156. 2006.
250.
SunMK, HongpaisanJ, NelsonTJ, AlkonDL. Poststroke neuronal rescue and synaptogenesis mediated in vivo by protein kinase C in adult brains. Proc Natl Acad Sci USA, 105:13620–13625. 2008.
251.
SundaresanM, YuZX, FerransVJ, IraniK, FinkelT. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science, 270:296–269. 1995.
252.
SupattaponeS, DanoffSK, TheibertA, JosephSK, SteinerJ, SnyderSH. Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium. Proc Natl Acad Sci USA, 85:8747–8750. 1988.
253.
TakahashiA, OhtaniN, YamakoshiK, IidaS, TaharaH, NakayamaK, NakayamaKI, IdeT, SayaH, HaraE. Mitogenic signaling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol, 8:1291–1297. 2006.
254.
TakaiY, KishimotoA, InoueM, NishizukaY. Studies on a cyclic nucleotide-independent protein kinase and its proenzyme in mammalian tissues. I. Purification and characterization of an active enzyme from bovine cerebellum. J Biol Chem, 252:7603–7609. 1977.
255.
TakekoshiK, IshiiK, NanmokuT, ShibuyaS, KawakamiY, IsobeK, NakaiT. Leptin stimulates catecholamine synthesis in a PKC-dependent manner in cultured porcine adrenal medullary chromaffin cells. Endocrinology, 142:4861–4871. 2001.
256.
TaliorI, TennenbaumT, KurokiT, Eldar–FinkelmanH. PKC-delta-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: Role for NADPH oxidase. Am J Physiol Endocrinol Metab, 288:E405–11. 2005.
257.
TamagnoE, ParolaM, BardiniP, PicciniA, BorghiR, GuglielmottoM, SantoroG, DavitA, DanniO, SmithMA, PerryG, TabatonM. Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem, 92:628–636. 2005.
258.
TapiaG, FernandezV, VarelaP, CornejoP, GuerreroJ, VidelaLA. Thyroid hormone-induced oxidative stress triggers nuclear factor-kappaB activation and cytokine gene expression in rat liver. Free Radic Biol Med, 35:257–265. 2003.
259.
TaylorCG, NagyLE, BrayTM. Nutritional and hormonal regulation of glutathione homeostasis. Curr Top Cell Regul, 34:189–208. 1996.
260.
ThompsonLJ, FieldsAP. betaII protein kinase C is required for the G2/M phase transition of cell cycle. J Biol Chem, 271:15045–15053. 1996.
261.
TokerA. Signaling through protein kinase C. Front Biosci, 3:D1134–1147. 1998.
262.
TomaiF. Warm up phenomenon and preconditioning in clinical practice. Heart, 87:99–100. 2002.
263.
TracyK, MacleodKF. Regulation of mitochondrial integrity, autophagy and cell survival by BNIP3. Autophagy, 3:616–619. 2007.
264.
TuttleKR. Protein kinase C-beta inhibition for diabetic kidney disease. Diabetes Res Clin Pract, 82:S70–74. 2008.
265.
VermaS, FedakPW, WeiselRD, ButanyJ, RaoV, MaitlandA, LiRK, DhillonB, YauTM. Fundamentals of reperfusion injury for the clinical cardiologist. Circulation, 105:2332–2336. 2002.
266.
VillalbaM, KasibhatlaS, GenestierL, MahboubiA, GreenDR, AltmanA. Protein kinase ctheta cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death. J Immunol, 163:5813–5819. 1999.
267.
WalkerWG, WheltonPK, SaitoH, RussellRP, HermannJ. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension, 1:287–291. 1979.
268.
WangY, TakashiE, XuM, AyubA, AshrafM. Downregulation of protein kinase C inhibits activation of mitochondrial K(ATP) channels by diazoxide. Circulation, 104:85–90. 2001.
269.
WardNE, PierceDS, ChungSE, GravittKR, O'BrianCA. Irreversible inactivation of protein kinase C by glutathione. J Biol Chem, 273:12558–12566. 1998.
270.
WatanabeT, OnoY, TaniyamaY, HazamaK, IgarashiK, OgitaK, KikkawaU, NishizukaY. Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies. Proc Natl Acad Sci USA, 89:10159–10163. 1992.
271.
WatsonJA, RumsbyMG, WolowaczRG. Phage display identifies thioredoxin and superoxide dismutase as novel protein kinase C-interacting proteins: Thioredoxin inhibits protein kinase C-mediated phosphorylation of histone. Biochem J, 343:301–305. 1999.
272.
WayKJ, KataiN, KingGL. Protein kinase C and the development of diabetic vascular complications. Diabet Med, 18:945–959. 2001.
273.
WheatonK, RiabowolK. Protein kinase C delta blocks immediate-early gene expression in senescent cells by inactivating serum response factor. Mol Cell Biol, 24:7298–7311. 2004.
274.
WhelanRD, ParkerPJ. Loss of protein kinase C function induces an apoptotic response. Oncogene, 16:1939–1944. 1998.
275.
WiernspergerNF, BaileyCJ. The antihyperglycaemic effect of metformin: Therapeutic and cellular mechanisms. Drugs, 58:31–39discussion 75–821999.
276.
WilleyJC, GrafstromRC, MoserCEJr., OzanneC, SundquvistK, HarrisCC. Biochemical and morphological effects of cigarette smoke condensate and its fractions on normal human bronchial epithelial cells in vitro. Cancer Res, 47:2045–2049. 1987.
277.
WuWS, TsaiRK, ChangCH, WangS, WuJR, ChangYX. Reactive oxygen species mediated sustained activation of protein kinase C alpha and extracellular signal-regulated kinase for migration of human hepatoma cell Hepg2. Mol Cancer Res, 4:747–758. 2006.
278.
WulfG, FinnG, SuizuF, LuKP. Phosphorylation-specific prolyl isomerization: Is there an underlying theme?Nat Cell Biol, 7:435–441. 2005.
279.
YamagishiSI, EdelsteinD, DuXL, KanedaY, GuzmanM, BrownleeM. Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem, 276:25096–25100. 2001.
280.
YangXM, SatoH, DowneyJM, CohenMV. Protection of ischemic preconditioning is dependent upon a critical timing sequence of protein kinase C activation. J Mol Cell Cardiol, 29:991–999. 1997.
281.
YuH, Oh–HashiK, TanakaT, SaiA, InoueM, HirataY, KiuchiK. Rehmannia glutinosa induces glial cell line-derived neurotrophic factor gene expression in astroglial cells via cPKC and ERK1/2 pathways independently. Pharmacol Res, 54:39–45. 2006.
282.
ZhangH, Bosch–MarceM, ShimodaLA, TanYS, BaekJH, WesleyJB, GonzalezFJ, SemenzaGL. Mitochondrial autophagy is an HIF-1-dependent adaptive metabolic response to hypoxia. J Biol Chem, 283:10892–10903. 2008.
283.
ZhouW, TakuwaN, KumadaM, TakuwaY. Protein kinase C-mediated bidirectional regulation of DNA synthesis, RB protein phosphorylation, and cyclin-dependent kinases in human vascular endothelial cells. J Biol Chem, 268:23041–23048. 1993.
284.
ZhouY, WangD, LiF, ShiJ, SongJ. Different roles of protein kinase C-betaI and -delta in the regulation of adipocyte differentiation. Int J Biochem Cell Biol, 38:2151–2163. 2006.
285.
ZhuDM, FangWH, NarlaRK, UckunFM. A requirement for protein kinase C inhibition for calcium-triggered apoptosis in acute lymphoblastic leukemia cells. Clin Cancer Res, 5:355–360. 1999.
286.
ZhuGH, WongBC, SlosbergED, EggoMC, ChingCK, YuenST, LaiKC, SohJW, WeinsteinIB, LamSK. Overexpression of protein kinase C-beta1 isoenzyme suppresses indomethacin-induced apoptosis in gastric epithelial cells. Gastroenterology, 118:507–514. 2000.
287.
ZorovDB, FilburnCR, KlotzLO, ZweierJL, SollottSJ. Reactive oxygen species (ROS)-induced ROS release: A new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med, 192:1001–1014. 2000.
